Do we have a breakthrough in the coronavirus? Scientists report an effective drug that has been known for 70 years

0
(0)

Jan , 27. 12. 2025

Article content

A glimmer of hope has appeared in the dark time of the coronavirus pandemic. Scientific research on infected patients in China has shown that a drug for the current COVID-19 pandemic not only exists, but we have had it available for 70 years! And it supposedly works great!

The population stands face to face with a raging pandemic of a deadly virus. Thousands of research laboratory capacities from around the world are laboring to create an effective vaccine or drug for the disease that plagues populations on every continent of planet Earth. It has, however, turned out that a drug known for nearly a hundred years can fight the virus excellently.

Scientists are basing their work on drugs already known

Antiretroviral treatment, which was originally prescribed to patients with the HIV virus, has proven to be effective also against the coronavirus. Likewise, drugs used against autoimmune hepatitis type C have shown effects in eliminating the dangerous mutated SARS-Cov-2 virus and, to great surprise, high intravenously administered doses of ascorbic acid, i.e., vitamin C, also work to some degree.

However, the breakthrough discovery was made by scientists from China, who tested a drug used to treat the autoimmune disease lupus erythematosus and rheumatoid arthritis called chloroquine against the coronavirus. It is also used against exotic diseases, such as malaria, and its effect completely surprised scientists. It has been known among doctors for over seventy years.

Human studies showed relief within ten days

The Chinese tested the drug on a hundred patients infected with the coronavirus from Wuhan, Beijing and Shanghai.

 

It turned out that 500 mg of chloroquine administered continuously for ten days resulted in huge changes in the patients’ health. The course of their illness improved literally from hour to hour until full recovery. The therapy also worked to reduce accompanying pneumonia.

The problem, however, is that this drug is not available in the medical warehouses and wholesalers of most countries. Countries that do have this substance available in their pharmacies are permitted to use it to treat infected patients.